Further study in a larger independent AL amyloidosis population is needed to fully validate and confirm our findings indicating that measurement of sST2 and GDF-15 provides additional prognostic value in AL patients with cardiac involvement. This evidence concerns the gene GDF15 and AL amyloidosis.